Case Study

From Challenge to Victory: TFS’s RWE EMA Success Story with a Pivotal Retrospective Study

November 4, 2023February 28th, 2025
TFS RWE Case Study

From Challenge to Victory: TFS’s RWE EMA Success Story with a Pivotal Retrospective Study

Download our case study to:

Delve into how TFS leveraged vast US real-world data to secure EMA approval for an extended-release CNS drug, bypassing traditional costly trials.

Witness how our RWE team’s innovative design and AI-assisted analyses cut costs by 30 times and accelerated timelines, achieving non-inferiority and even superiority in key endpoints. Download now to uncover the RWE-driven breakthroughs that delivered this triumph.

Learn more about our related services and resources:

Phase IV-RWE

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Real World Evidence Expertise

Top 10 CROs to watch in 2025
Top 10 Contract Research Organizations (CROs) for 2025Article

Top 10 Contract Research Organizations (CROs) for 2025

Discover the top 10 CROs in 2025. Learn about industry leaders in clinical trials, technology adoption, & global healthcare solutions.
Harnessing Real-World Evidence (RWE) for Effective External Control Arms in Clinical TrialsWhite paper

Harnessing Real-World Evidence (RWE) for Effective External Control Arms in Clinical Trials

This white paper is a comprehensive guide into regulatory perspectives, practical applications, and the future of clinical research in RWE.
how to leverage real-world evidence (RWE) and specialized oncology CROs when conducting early-phase oncology clinical trials
Leveraging Real-World Evidence (RWE) in Early-Phase Oncology ResearchArticle

Leveraging Real-World Evidence (RWE) in Early-Phase Oncology Research

Explore how to leverage real-world evidence (RWE) and specialized oncology CROs when conducting early-phase oncology clinical trials.